Choosing to Enjoy Life Despite Metastatic Breast Cancer

Lisa’s breast cancer had already spread to her bones when she was first diagnosed. The cancer continued to spread until Lisa started taking olaparib, a PARP inhibitor for treating patients with BRCA mutations. Learn more in the AACR Cancer Progress Report 2018, www.CancerProgressReport.org.

• Kategorija